par Vincent, Jean Louis 
;Marshall, John C;Dellinger, Richard Phillip;Simonson, Steven S.G.;Guntupalli, Kalpalatha;Levy, Mitchell;Singer, Mervyn;Malik, Rajesh
Référence Critical care medicine, 43, 9, page (1832-1838)
Publication Publié, 2015-09
;Marshall, John C;Dellinger, Richard Phillip;Simonson, Steven S.G.;Guntupalli, Kalpalatha;Levy, Mitchell;Singer, Mervyn;Malik, RajeshRéférence Critical care medicine, 43, 9, page (1832-1838)
Publication Publié, 2015-09
Article révisé par les pairs
| Résumé : | OBJECTIVE: Talactoferrin alfa is a recombinant form of the human glycoprotein, lactoferrin, which has been shown to have a wide range of effects on the immune system. This phase II/III clinical trial compared talactoferrin with placebo, in addition to standard of care, in patients with severe sepsis. |
